The NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) has documented a high prevalence of coronary vascular dysfunction in women with symptoms and evidence of ischemia with no obstructive CAD. The condition is associated with an adverse prognosis and healthcare costs similar to obstructive CAD, there are an estimated 2-3 million women with existent disease, and a projected 100,000 new cases annually. This places the prevalence, morbidity and costs of coronary vascular dysfunction higher than all female reproductive cancers combined. Prospective testing of a noninvasive approach for diagnosis and prognosis is needed as critical next steps toward translation of our findings into clinical care. Using a prospective cohort design with follow-up, we aim to investigate: 1) Abnormal cardiac magnetic resonance imaging (CMRI) predicts abnormalities in coronary reactivity testing (CRT);2) Persistent cardiac magnetic resonance imaging (CMRI) abnormalities at 1-year follow-up predict persistent symptoms of ischemia;3) CMRI predicts adverse outcomes, and thus can be used as an outcome in future therapeutic trials. The baseline study visit will include a physical exam and elicitation of medical history, symptoms, lifestyle and functional characteristics, and psychosocial status. We will recruit 375 women undergoing coronary angiography for suspected ischemia with no obstructive CAD. All 375 will undergo baseline CMRI imaging, and a subgroup of 200 will undergo repeat one-year follow-up CMRI. An additional subgroup of 200 women with no coronary stenosis >20% in any epicardial coronary artery will undergo CRT. Women will be contacted annually to measure outcome of symptoms, coronary events, and associated costs. Established WISE core laboratories and clinical sites will be used. Documentation of the link between invasive CRT and noninvasive CMRI imaging, and the prognostic value of this measure for symptoms and adverse outcomes, will provide a platform for clinical trials to test therapeutic interventions in appropriately powered studies. Potential therapeutic trials being planned include anti-ischemia therapies, such as ranolazine and dipyridamole, as well as novel interventions, such as erythropoietin and stem-cell therapy, targeting coronary vascular function. Results of the application will provide practicing physicians with the ability to translate these findings to clinical care to improve IHD outcomes in women using a noninvasive assessment strategy.

Public Health Relevance

Registry data indicate that most women with coronary vascular dysfunction remain untreated with evidence-based care. Further investigation into approaches to the noninvasive assessment coronary vascular dysfunction is needed to improve clinical care and lower health care cost for women.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
3R01HL090957-04S1
Application #
8734622
Study Section
Cardiovascular and Sleep Epidemiology (CASE)
Program Officer
Sopko, George
Project Start
2008-09-17
Project End
2014-08-31
Budget Start
2011-07-01
Budget End
2014-08-31
Support Year
4
Fiscal Year
2013
Total Cost
$500,000
Indirect Cost
$200,599
Name
Cedars-Sinai Medical Center
Department
Type
DUNS #
075307785
City
Los Angeles
State
CA
Country
United States
Zip Code
90048
Shufelt, Chrisandra; Elboudwarej, Omeed; Johnson, B Delia et al. (2016) Carotid artery distensibility and hormone therapy and menopause: the Los Angeles Atherosclerosis Study. Menopause 23:150-7
Weng, Liming; Taylor, Kent D; Chen, Yii-Der Ida et al. (2016) Genetic loci associated with nonobstructive coronary artery disease in Caucasian women. Physiol Genomics 48:12-20
Wei, Janet; Nelson, Michael D; Szczepaniak, Edward W et al. (2016) Myocardial steatosis as a possible mechanistic link between diastolic dysfunction and coronary microvascular dysfunction in women. Am J Physiol Heart Circ Physiol 310:H14-9
Enkhmaa, Davaasambuu; Wall, Danielle; Mehta, Puja K et al. (2016) Preeclampsia and Vascular Function: A Window to Future Cardiovascular Disease Risk. J Womens Health (Larchmt) 25:284-91
Smith, Steven M; Huo, Tianyao; Gong, Yan et al. (2016) Mortality Risk Associated With Resistant Hypertension Among Women: Analysis from Three Prospective Cohorts Encompassing the Spectrum of Women's Heart Disease. J Womens Health (Larchmt) 25:996-1003
Mehta, Puja K; Minissian, Margo; Bairey Merz, C Noel (2016) Stroke in women: Where are we in 2015? Trends Cardiovasc Med 26:89-91
Mian, Zainab; Wei, Janet; Bharadwaj, Meghan et al. (2016) Prior myocardial infarction is associated with coronary endothelial dysfunction in women with signs and symptoms of ischemia and no obstructive coronary artery disease. Int J Cardiol 207:137-9
Shufelt, Chrisandra; Braunstein, Glenn D; Pepine, Carl J et al. (2015) Recognizing Sex Similarities in Cardiovascular Disease Research. J Am Coll Cardiol 65:2152-3
Shufelt, Chrisandra; Waldman, Talya; Wang, Erica et al. (2015) Female-specific factors for IHD: across the reproductive lifespan. Curr Atheroscler Rep 17:481
Khaliq, Asma; Johnson, B Delia; Anderson, R David et al. (2015) Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation Study. Cardiovasc Endocrinol 4:45-52

Showing the most recent 10 out of 48 publications